ABS1022 USE OF CANNABIS LIQUID PLANT EXTRACT 10 mg/ml Δ9-TETRAHYDROCANNABINOL AND 10 mg/ml CANNABIDIOL IN PATIENTS WITH FIBROMYALGIA SYNDROME
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/AAI Classification
InconclusiveFine-tuned Classification
N/AClinical and psychosocial changes in adults with opioid use disorder and chronic pain using medical cannabis: a brief report